Semaglutide effects on cardiovascular outcomes in people with overweight or obesity

Clinical Trial Grant

Duke Scholars

Principal Investigator Hiba Abou Assi Medicine, Endocrinology, Metabolism, and Nutrition

Administered By

Duke Molecular Physiology Institute

Awarded By

Novo Nordisk, Inc.

Start Date

March 22, 2019

End Date

March 31, 2023

Administered By

Duke Molecular Physiology Institute

Awarded By

Novo Nordisk, Inc.

Start Date

March 22, 2019

End Date

March 31, 2023